Literature DB >> 19127322

Left ventricular assist device as a bridge to recovery in a young woman admitted with peripartum cardiomyopathy.

L Oosterom1, N de Jonge, J Kirkels, C Klöpping, J Lahpor.   

Abstract

Left ventricular assist devices (LVAD) are an effective therapeutic option for end-stage heart failure patients as a bridge to cardiac transplantation in those who deteriorate despite maximal therapy and when a donor heart is not ready available. In some patients, cardiac recovery has been reported while supported by an LVAD. In this case report, we describe a 29-year-old female who was admitted to our centre because of peripartum cardiomyopathy (PPCM). Despite intensive treatment with intravenous inotropes and intra-aortic balloon counter-pulsation she had a persisting low cardiac index and an LVAD was implanted. In the months following implantation the left ventricular systolic function improved and the left ventricular dimensions normalised. Eventually the LVAD could be ex-planted nine months after implantation. At this moment, three years after explantation, echo-cardiography shows a normal-sized left ventricle and almost completely recovered systolic function. (Neth Heart J 2008;16:426-8).

Entities:  

Keywords:  bridge to recovery; cardiac transplantation; left ventricular assist device (LVAD); peripartum cardiomyopathy (PPCM)

Year:  2008        PMID: 19127322      PMCID: PMC2612113          DOI: 10.1007/BF03086192

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  16 in total

1.  A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery.

Authors:  M H Yacoub
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

2.  Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments.

Authors:  Nicolaas de Jonge; Dick F van Wichen; Marguerite E I Schipper; Jaap R Lahpor; Frits H J Gmelig-Meyling; Etienne O Robles de Medina; Roel A de Weger
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

3.  Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices.

Authors:  Michael Dandel; Yuguo Weng; Henryk Siniawski; Evgenij Potapov; Hans B Lehmkuhl; Roland Hetzer
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

Review 4.  Peripartum cardiomyopathy: a comprehensive review.

Authors:  John Abboud; Yahya Murad; Carol Chen-Scarabelli; Louis Saravolatz; Tiziano M Scarabelli
Journal:  Int J Cardiol       Date:  2007-01-17       Impact factor: 4.164

5.  Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.

Authors:  Simon Maybaum; Donna Mancini; Steve Xydas; Randall C Starling; Keith Aaronson; Francis D Pagani; Leslie W Miller; Kenneth Margulies; Susan McRee; O H Frazier; Guillermo Torre-Amione
Journal:  Circulation       Date:  2007-05-07       Impact factor: 29.690

6.  Improved outcomes in peripartum cardiomyopathy with contemporary.

Authors:  Ankie M Amos; Wissam A Jaber; Stuart D Russell
Journal:  Am Heart J       Date:  2006-09       Impact factor: 4.749

Review 7.  Peripartum cardiomyopathy.

Authors:  Karen Sliwa; James Fett; Uri Elkayam
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

8.  Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure.

Authors:  D M Mancini; A Beniaminovitz; H Levin; K Catanese; M Flannery; M DiTullio; S Savin; M E Cordisco; E Rose; M Oz
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

9.  Left ventricular assist device as a bridge to recovery in a young woman admitted with peripartum cardiomyopathy.

Authors:  L Oosterom; N de Jonge; J Kirkels; C Klöpping; J Lahpor
Journal:  Neth Heart J       Date:  2008-12       Impact factor: 2.380

10.  Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure.

Authors:  K Dipla; J A Mattiello; V Jeevanandam; S R Houser; K B Margulies
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

View more
  9 in total

1.  Expected and unexpected cardiac problems during pregnancy.

Authors:  P G Pieper
Journal:  Neth Heart J       Date:  2008-12       Impact factor: 2.380

2.  [Peripartum cardiomyopathy: interdisciplinary challenge].

Authors:  B Löser; S Tank; G Hillebrand; B Goldmann; W Diehl; D Biermann; J Schirmer; D A Reuter
Journal:  Anaesthesist       Date:  2013-05       Impact factor: 1.041

3.  Left ventricular assist device as a bridge to recovery in a young woman admitted with peripartum cardiomyopathy.

Authors:  L Oosterom; N de Jonge; J Kirkels; C Klöpping; J Lahpor
Journal:  Neth Heart J       Date:  2008-12       Impact factor: 2.380

Review 4.  Cardiovascular adverse events in pregnancy: A global perspective.

Authors:  Susy Kotit; Magdi Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2021-04-30

5.  Peripartum cardiomyopathy: the need for a national database.

Authors:  S I Lok; J H Kirkels; C Klöpping; P A F Doevendans; N de Jonge
Journal:  Neth Heart J       Date:  2011-01-27       Impact factor: 2.380

6.  Acute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices.

Authors:  Sofie Gevaert; Yves Van Belleghem; Stefaan Bouchez; Ingrid Herck; Filip De Somer; Yasmina De Block; Fiona Tromp; Els Vandecasteele; Floor Martens; Michel De Pauw
Journal:  Crit Care       Date:  2011-03-10       Impact factor: 9.097

7.  Myocardial recovery in peri-partum cardiomyopathy after continuous flow left ventricular assist device.

Authors:  Lars H Lund; Karl-Henrik Grinnemo; Peter Svenarud; Jan van der Linden; Maria J Eriksson
Journal:  J Cardiothorac Surg       Date:  2011-11-14       Impact factor: 1.637

8.  Treatment options in end-stage heart failure: where to go from here?

Authors:  M L A Haeck; G E Hoogslag; S F Rodrigo; D E Atsma; R J Klautz; E E van der Wall; M J Schalij; H F Verwey
Journal:  Neth Heart J       Date:  2012-04       Impact factor: 2.380

Review 9.  Ventricular Assist Devices and Their Usage as a Bridge to Recovery in Patients With Acute Cardiotoxicity and Cardiomyopathy.

Authors:  Suyeewin Thiha; Chris A Robert; Abdul Rehman Z Zaidi
Journal:  Cureus       Date:  2020-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.